Catalytic domain comparisons of human fibroblast-type collagenase, stromelysin-1, and matrilysin

被引:11
|
作者
Windsor, LJ
Steele, DL
LeBlanc, SB
Taylor, KB
机构
[1] UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294
[2] UNIV ALABAMA,DEPT BIOCHEM & MOL GENET,BIRMINGHAM,AL 35294
来源
关键词
matrix metalloproteinase; collagenase; matrilysin; stromelysin;
D O I
10.1016/S0304-4165(96)00102-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The propeptide plus the catalytic domain of human fibroblast-type collagenase, stromelysin-1, and matrilysin were expressed in Escherichia coli to directly compare the properties of all three catalytic domains utilizing the same assays. Truncated fibroblast-type collagenase (mini-CL), truncated stromelysin-l (mini-SL-1), and matrilysin, like their native counterparts, could be activated by organomercurials, trypsin, or SDS. The mini-CL and mini-SL-l displayed catalytic properties similar to their native counterparts, except that the mini-CL could not cleave native type I collagen. The k(cat)/K-m for matrilysin (355 mu M(-1) h(-1)) on the synthetic Mca-peptide was much higher than that for mini-CL (69 mu M(-1) h(-1)) or mini-SL-1 (23.6 mu M(-1) h(-1)). Mini-SL-1 and matrilysin, but not mini-CL, were capable of superactivating collagenase thus increasing the rate of collagen cleavage. Mini-CL and mini-SL-1, but not matrilysin, were able to form SDS-stable complexes with TEMP-1 when co-incubated with an organomercurial and TIMP-1. The second-order rate constant (k(on)) for TEMP-1 inhibition of mini-CL and mini-SL-1 were similar, 0.635 . 10(5) M(-1) s(-1) and 1.52 . 10(5) M(-1) s(-1), respectively. The k(on) for TIMP-1 inhibition of matrilysin was lower (0.130 . 10(5) M(-1) s(-1)) supporting the observation that no SDS stable complexes were detected. This study demonstrates that these catalytic domains are distinct and play a major role in the specificity of these enzymes in regard to rate of catalysis, TIMP-1 binding, and superactivation of collagenase.
引用
收藏
页码:261 / 272
页数:12
相关论文
共 50 条
  • [31] STRUCTURE OF THE CATALYTIC DOMAIN OF FIBROBLAST COLLAGENASE COMPLEXED WITH AN INHIBITOR
    LOVEJOY, B
    CLEASBY, A
    HASSELL, AM
    LONGLEY, K
    LUTHER, MA
    WEIGL, D
    MCGEEHAN, G
    MCELROY, AB
    DREWRY, D
    LAMBERT, MH
    JORDAN, SR
    SCIENCE, 1994, 263 (5145) : 375 - 377
  • [32] Association of haplotypes of collagenase-1 and stromelysin-1 polymorphisms with erosive status in early rheumatoid arthritis
    Constantin, A.
    Gourraud, P-A
    Boyer, J. F.
    Nigon, D.
    Faucon, B.
    Jamard, B.
    Cambon-Thomsen, A.
    Davignon, J. L.
    Cantagrel, A.
    TISSUE ANTIGENS, 2008, 71 (04): : 342 - 342
  • [33] ULTRAVIOLET-A IRRADIATION UP-REGULATES STROMELYSIN-1 EXPRESSION IN PARALLEL WITH COLLAGENASE IN CULTURED HUMAN SKIN FIBROBLASTS
    PETERSEN, M
    LI, HL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (04) : 623 - 623
  • [34] Understanding the P-1' specificity of the matrix metalloproteinases: Effect of S-1' pocket mutations in matrilysin and stromelysin-1
    Welch, AR
    Holman, CM
    Huber, M
    Brenner, MC
    Browner, MF
    VanWart, HE
    BIOCHEMISTRY, 1996, 35 (31) : 10103 - 10109
  • [35] Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin)
    Agnihotri, R
    Crawford, HC
    Haro, H
    Matrisian, LM
    Havrda, MC
    Liaw, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (30) : 28261 - 28267
  • [36] A RECOMBINANT HUMAN STROMELYSIN CATALYTIC DOMAIN IDENTIFYING TRYPTOPHAN DERIVATIVES AS HUMAN STROMELYSIN INHIBITORS
    YE, QZ
    JOHNSON, LL
    NORDAN, I
    HUPE, D
    HUPE, L
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (01) : 206 - 209
  • [37] A RECOMBINANT HUMAN STROMELYSIN CATALYTIC DOMAIN IDENTIFIES TRYPTOPHAN DERIVATIVES AS HUMAN STROMELYSIN INHIBITORS
    YE, QZ
    JOHNSON, LL
    NORDAN, I
    HUPE, D
    HUPE, L
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 149 - 149
  • [38] High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma
    Nikkola, J
    Vihinen, P
    Vlaykova, T
    Hahka-Kemppinen, M
    Kähäri, VM
    Pyrhönen, S
    INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (04) : 432 - 438
  • [39] TRANSCRIPTIONAL ACTIVATION OF FIBROBLAST STROMELYSIN-1 GENE-EXPRESSION BY A NOVEL LYMPHOKINE, LEUKOREGULIN
    MAUVIEL, A
    KAHARI, VM
    KURKINEN, M
    EVANS, CH
    UITTO, J
    CLINICAL RESEARCH, 1992, 40 (02): : A307 - A307
  • [40] HUMAN FIBROBLAST STROMELYSIN CATALYTIC DOMAIN - EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF A C-TERMINALLY TRUNCATED FORM
    MARCY, AI
    EIBERGER, LL
    HARRISON, R
    CHAN, HK
    HUTCHINSON, NI
    HAGMANN, WK
    CAMERON, PM
    BOULTON, DA
    HERMES, JD
    BIOCHEMISTRY, 1991, 30 (26) : 6476 - 6483